Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Ways To Improve Monthly Budgeting With Analysis guides you to translate insights into concrete budget tweaks that save money.
21,748 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
February brought a sharp drop for Atlassian as investors digested earnings signals and AI risk. This guide breaks dow...
CleanSpark led February bitcoin production among three miners, while Cango and BitFuFu together added more than 700 B...
A breakthrough announcement from OpenAI reshapes AI investing around Amazon. Learn what happened, why it matters, and...
As Mach Natural Resources (MNR) reports Q4 2025 results, investors should focus on cash flow, capital allocation, and...
NVIDIA unveiled the Vera Rubin platform at GTC, pairing new Rubin GPUs with an 88-core Vera CPU and forecasting $1 tr...
Uber unveils a multiyear pact to invest up to $1.25 billion in Rivian, aiming to roll out up to 50,000 autonomous Riv...
Warren Buffett recalibrates how he donates, moving away from a single grand plan toward annual gifts routed through h...
Fresh demand signals and disciplined supply dynamics are setting up Micron stock for potential upside. This guide bre...
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
A prominent crypto trader files a lawsuit against Coinbase claiming it refused to return DAI funds stolen in a phishi...
Gary Vaynerchuk is delivering a blunt rallying cry on AI: dedicate at least an hour daily to hands-on AI work. The me...